Stocks
Nektar Therapeutics (NKTR) Debt/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 2.31 | 1.28 | 1.15 | 1.15 | 0.30 | 0.96 | ||
| Changes by years, y/y, % | -4% | -45% | -10% | +0% | -74% | |||
Nektar Therapeutics. Debt/EBITDA
Nektar Therapeutics. Debt/EBITDA, changes, %
Nektar Therapeutics (NKTR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.83 | 0.55 | 0.44 | 0.35 | 0.96 | 0.96 | ||
| Changes by years, y/y, % | +44% | -67% | -80% | -84% | -48% | |||
| Changes by quarters, q/q, % | -15% | -70% | -20% | -20% | +171% | |||
